TRELEGY is now approved for adult asthma patients aged 18 and older.
TRELEGY is NOT indicated for relief of acute bronchospasm.
The first and only once-daily triple therapy in a single inhaler for adult patients with asthma.
Available in two strengths for adult patients with asthma:
More information about TRELEGY